Lannett Company التزامات 2024

ماذا تفعل Lannett Company؟

Lannett Company Inc is a pharmaceutical company based in Philadelphia, Pennsylvania, USA. It was founded in 1942 by the Lannett brothers, Samuel and Robert. Initially, the company supplied raw materials to other pharmaceutical companies, but after a few years, it began producing its own generics. Lannett Company Inc's business model is based on the manufacturing, marketing, and sale of generic drugs. Generics are medications that contain the same active ingredient as a brand-name drug but can be offered at a much lower price because the research and development, as well as marketing costs, have already been covered by the original manufacturer of the brand-name drug. The company specializes in difficult-to-produce or limited generic drugs and offers numerous generics in various therapy areas such as anesthetics, painkillers, antidepressants, hypnotics, gynecology, and neurology. Lannett Company Inc has various business segments to promote its growth and market presence. One segment is the marketing of established products, which focuses on selling products that have already been introduced to the market and have an established customer base. Another segment is the sale of new products, where the company introduces new generics to the market that have not yet been offered by other manufacturers. Additionally, the company also provides development and manufacturing services for other pharmaceutical companies that wish to distribute drugs under their own brand name. Some of the key products offered by Lannett Company Inc include anesthetics such as Propofol and Etomidate, lidocaine-containing local anesthetics, painkillers such as Oxycodone-APAP, antidepressants such as Amitriptyline, hypnotics such as Zolpidem, and gynecology products such as ovulation inducers and uterine stimulants. The company also has a presence in the field of neurology with drugs used to treat epilepsy and Parkinson's disease. As part of its growth strategy, Lannett Company Inc has also conducted acquisitions in recent years. In 2015, the company acquired Cody Laboratories Inc., a company specializing in the production of difficult-to-produce products such as narcotics and steroids. In 2018, the company acquired Kremers Urban Pharmaceuticals, a manufacturer of generics and specialty products used in the treatment of chronic pain, migraines, nausea, and other conditions. Overall, Lannett Company Inc has experienced strong growth in recent years and expanded its market presence. The company is committed to expanding its portfolio of generic drugs and engaging in new therapy areas. It also pursues a growth-oriented strategy through acquisitions and partnerships with other pharmaceutical companies to strengthen its market position. Lannett Company ist eines der beliebtesten Unternehmen auf Eulerpool.com.